AR - 医索

找到约 3151 条结果

Exploring New Partnerships in HER2-Positive Breast Cancer

医客学院 - 会议报告集

Elucidating the lmmune Active State of HR HER2.MammaPrint High 2 Early Breast Cancer

医客学院 - 会议报告集

ECOG-ACRIN EAZ171 Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TlPN) in Black women with early-stage breast cancer

医客学院 - 会议报告集

Comparison antitumor efficacy Of first-line Of Palbociclib, Ribociclib or Abemaciclib in patients with HR HER2-aBC results of the multicenter, real-world,Italian study PALMARES-2

医客学院 - 会议报告集

Clinical utility of molecular imagingin newly diagnosed metastatic breastcancerIMPACT-MBC study

医客学院 - 会议报告集

Baseline characteristics and efficacyendpoints for patients with node-negativeHR HER2-early breast cancer in NATALEE

医客学院 - 会议报告集

Associations of predictive biomarkers(MHC-I and MHC-ll) with clinical and molecularfeatures in a diverse preast cancer cohort

医客学院 - 会议报告集

Association of MammaPrint index and 3-yearoutcome of patients in the FLEX Registry trial withHR HER2-early-stage breast cancer treated withchemotherapy with or without anthracycline

医客学院 - 会议报告集

ACE-Breast-02 a pivotal phase lllll trial of ARX788, anovel anti-HER2 ADC, vs lapatinib plus capecitabine forHER2 advanced breast cancer

医客学院 - 会议报告集

Abemaciclib plus fulvestrant vs fulvestrant alone for HR HER2-advanced breast cancer following progression onprior CDK46 inhibitor plus endocrine therapy Primaryoutcome of the Phase 3 postMONARCH

医客学院 - 会议报告集

今日实时热搜